Aim
The Open University is seeking an industry collaborator to join a consortium including world-leading institutions for a large, international bid.
We are looking for a company specialised in small-interfering RNA (siRNA) drug delivery systems (ideally lipid or silica nanoparticles) to join a consortium of partners for a large international bid, which includes world-leading institutions.
Description
Our lab develops precision epigenetic therapies for incurable prostate cancer.
We are looking for a company specialised in small-interfering RNA (siRNA) drug delivery systems (ideally lipid or silica nanoparticles) to join a consortium of partners for a large international bid, which includes world-leading institutions.
We are particularly interested in approaches that increase tumour specific delivery (e.g. functionalisation, hypoxia-dependent delivery).
We are open to other drug delivery systems, but we will give priority to those that are more advanced towards clinical testing.
About The Open University
Our network of national and regional centres in England, Scotland, Wales and Northern Ireland makes us uniquely placed to develop partnerships throughout the UK.
The OU also has leading laboratory facilities at our Milton Keynes headquarters, and specialised laboratories for biodegradability, pervasive computing and electron microscopy. Our Research Institutes specialise in AI and Educational Technology and conduct pioneering research into the generation, understanding and sharing of knowledge in different media.
The role of the OU’s Commercial Operations Team is to help you access our knowledge and facilities in the best way for your organisation.
Next Steps
If this is of interest to you, please CONNECT through konfer, we are open to any and all discussions and welcome your interest.
Collaboration: The Open University
Information provided by The Open University.
